![Nancy Mathias](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nancy Mathias
Corporate Officer/Principal at Michael Smith Foundation for Health Research
Network origin in Nancy Mathias first degree
Entity | Entity type | Industry | |
---|---|---|---|
Michael Smith Foundation for Health Research
![]() Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012.
7
| Non-Profit Organization | Investment Trusts/Mutual Funds | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nancy Mathias via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Executive Officer | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
National University of Singapore | College/University | Corporate Officer/Principal | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder | |
McGill University | College/University | Undergraduate Degree | |
Andera Partners SCA
![]() Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Consultant / Advisor | |
University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Manitoba | College/University | Doctorate Degree | |
University of Calgary | College/University | Corporate Officer/Principal | |
University of Cape Town | College/University | Doctorate Degree | |
Active Pass Pharmaceuticals, Inc.
![]() Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member | |
MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member | |
Agency for Science, Technology & Research
![]() Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
Richardson Capital Ltd.
![]() Richardson Capital Ltd. Investment ManagersFinance Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada. | Investment Managers | Corporate Officer/Principal | |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
Premier's Technology Council | General Government | Corporate Officer/Principal | |
American Society of Human Genetics
![]() American Society of Human Genetics Miscellaneous Commercial ServicesCommercial Services The American Society of Human Genetics operates as a membership organization for human geneticists. The non-profit company is based in Bethesda, MD. | Miscellaneous Commercial Services | Director/Board Member | |
American Society of Clinical Investigation | Corporate Officer/Principal | ||
Canadian Genetics Diseases Network
![]() Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Multiple Sclerosis Society of Canada
![]() Multiple Sclerosis Society of Canada Investment Trusts/Mutual FundsMiscellaneous Multiple Sclerosis Society of Canada provides funding for research and education services related to multiple sclerosis. The non-profit company is based in Toronto, Canada. The CEOs of the Canadian company are Pamela Valentine, Yves Savoie. | Investment Trusts/Mutual Funds | Director/Board Member | |
Adherium (NZ) Ltd.
![]() Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Packaged Software | Director/Board Member | |
Royal Society of Canada
![]() Royal Society of Canada Miscellaneous Commercial ServicesCommercial Services The Royal Society of Canada offers educational courses. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Iris Almeida-Cote. | Miscellaneous Commercial Services | Director/Board Member | |
Centre for Molecular Medicine & Therapeutic | Founder | ||
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Consultant / Advisor | |
NeuroVir Therapeutic, Inc.
![]() NeuroVir Therapeutic, Inc. Pharmaceuticals: MajorHealth Technology Part of MediGene AG, NeuroVir Therapeutic, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company is based in San Diego, CA. The company was founded by Michael R. Hayden, Frank Tufaro. NeuroVir Therapeutic was acquired by MediGene AG on January 12, 2001 for $53 million. | Pharmaceuticals: Major | Founder | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member | |
REX BIONICS PLC | Medical Specialties | Director/Board Member | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ABCELLERA BIOLOGICS INC. | Biotechnology | Director/Board Member | |
ADHERIUM LIMITED | Medical Specialties | Director/Board Member | |
Soundbite Medical Solutions, Inc.
![]() Soundbite Medical Solutions, Inc. Medical SpecialtiesHealth Technology SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada. | Medical Specialties | Director/Board Member | |
Translational Laboratory in Genetic Medicine | Director/Board Member | ||
Summatix Pty Ltd.
![]() Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Internet Software/Services | Director/Board Member | |
Canary Medical, Inc.
![]() Canary Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada. | Electronic Equipment/Instruments | Chief Executive Officer | |
89BIO, INC. | Pharmaceuticals: Major | Founder | |
Prilenia Therapeutics Development Ltd.
![]() Prilenia Therapeutics Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Prilenia Therapeutics BV, Prilenia Therapeutics Development Ltd. is a clinical stage biotech company based in Herzliya, Israel. Prilenia Therapeutics is developing its lead drug candidate, pridopidine, which is a sigma-1 receptor agonist and is in clinical development for the treatment of ALS and Huntington's disease. Pridopidine is currently part of the Healey ALS platform phase 2/3 clinical study and is in a phase 3 trial (PROOF-HD) with the Huntington Study Group, addressing functional capacity in early-stage HD patients. The pridopidine pipeline includes further indications in the pre-clinical phase. The Israeli company was founded by Michael R. Hayden in 2018 with the purpose of developing treatments for neurodegenerative and neurodevelopmental disorders. | Miscellaneous Commercial Services | Founder | |
Prilenia Therapeutics BV
![]() Prilenia Therapeutics BV BiotechnologyHealth Technology Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands. | Biotechnology | Founder | |
GlobaR&D Co. ,Ltd | President |
Statistics
International
Canada | 24 |
United States | 10 |
United Kingdom | 4 |
Singapore | 4 |
Australia | 4 |
Sectoral
Health Technology | 23 |
Finance | 7 |
Consumer Services | 7 |
Commercial Services | 6 |
Technology Services | 3 |
Operational
Director/Board Member | 36 |
Independent Dir/Board Member | 10 |
Founder | 9 |
Corporate Officer/Principal | 9 |
Chief Executive Officer | 5 |
Most connected contacts
Insiders | |
---|---|
Michael Hayden | 27 |
Bill Hunter | 22 |
Thomas Feasby | 5 |
Sally Thorne | 1 |
Michael Hayden | 1 |
Lori Last | 1 |
Diane Finegood | 1 |
- Stock Market
- Insiders
- Nancy Mathias
- Company connections